search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


16 resulaten gevonden voor Non Hodkin's lymfoma (NHL) in trials

TARC IN PATIENTS WITH LYMPHADENOPATH, FEVER OR NON-HODGKIN LYMPHOMA
- TRIAL ID
NTR6994
- ACRONYMTARC-002
Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphoma
- TRIAL ID
NTR4602
- ACRONYMHOVON 127 BL
Efficienty of vaccination in patients with cancer who are treated with chemotherapy.
- TRIAL ID
NTR3155
- ACRONYMRITUXIVAC
Zevalin-BEAM or Zevalin as consolidation in patients with transformed lymphoma.
- TRIAL ID
NTR2338
- ACRONYM
Efficacy and safety of a single dose of 14.8 MBq/kg (0.4 mCi/kg)90Y-ibritumomab tiuxetan ("Zevalin") in elderly patients with diffuse large B-cell lymphoma and FDG-PET positive partial remission following first-line R-CHOP therapy. A Phase II clinical trial (HOVON 77).
- TRIAL ID
NTR2086
- ACRONYMHOVON 77 NHL
Distress and quality of life in autologous stem cell transplantation: stepped care.
- TRIAL ID
NTR1770
- ACRONYMSTEC-2
Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation.
- TRIAL ID
NTR1757
- ACRONYMHOVON 80 NHL
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor.
- TRIAL ID
NTR1573
- ACRONYMEngraftment after double cord blood transplantation.
Positron Emission Tomography for detection of histologic transformation of indolent non-Hodgkin’s lymphoma: a pilot study
- TRIAL ID
NTR1487
- ACRONYMN/A
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.
- TRIAL ID
NTR1380
- ACRONYMHOVON 85 NHL
Randomized phase III study of Rituximab with intensified CHOP chemotherapy vs. Rituximab with High-Dose Sequential Therapy and Autologous Stem Cell Transplantation in Adult Patients (18-65 yrs) with Stage II-IV High-intermediate or High Risk DLBCL.
- TRIAL ID
NTR556
- ACRONYMHOVON 63 NHL
Protection against chemotherapy induced damage in the digestive tract in childhood cancer patients.
- TRIAL ID
NTR401
- ACRONYMN/A
Effect of recombinant G-CSF on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin’s Lymphoma. A prospective phase III study.
- TRIAL ID
NTR320
- ACRONYMHOVON 25 NHL
Intensified CHOP of 12-weeks duration plus G-CSF as compared with standard CHOP of 24-weeks duration for patients with intermediate-prognosis Non Hodgkin’s Lymphoma.
- TRIAL ID
NTR239
- ACRONYMHOVON 26 NHL
A randomized phase III study on the effect of the chimeric anti-CD20 monoclonal antibody (MabThera) during sequential chemotherapy followed by autologous stem cell transplantation in patients with relapsed or progressive B-cell non-Hodgkin’s lymphoma.
- TRIAL ID
NTR188
- ACRONYMHOVON 44 NHL
A randomized phase III study of chimeric anti-CD20 monoclonal antibody (Rituximab) with 2-weekly CHOP chemotherapy (CHOP 14) in elderly patients with intermediate- or high-risk non-Hodgkin’s lymphoma.
- TRIAL ID
NTR184
- ACRONYMHOVON 46 NHL